SEHK:2197Biotechs
Clover Biopharmaceuticals Full Year 2024 Earnings: CN¥0.72 loss per share (vs CN¥0.11 loss in FY 2023)
Clover Biopharmaceuticals ( HKG:2197 ) Full Year 2024 Results Key Financial Results Net loss: CN¥903.4m (loss widened...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.